Back to Results
First PageMeta Content
Health / 4-Hydroxy-3-nitrobenzenearsonic acid / Nitrobenzenes / Phenols / Arsenic / Chicken / Center for Veterinary Medicine / Center for Food Safety and Applied Nutrition / Pfizer / Chemistry / Medicine / Food and Drug Administration


FDA Media Call FDA Study Findings Leading to the Suspension of 3-Nitro (Roxarsone) Sales Moderator: Stephanie Yao June 8, 2011 Coordinator:
Add to Reading List

Open Document

File Size: 65,28 KB

Share Result on Facebook

Company

Wall Street Journal / the Associated Press / Pfizer / Alpharma / /

Country

Turkey / United States / /

Event

Product Issues / Product Recall / /

Facility

FDA Center / /

IndustryTerm

arsenic-based products / processed egg products / pharmaceutical / regulatory systems / drug manufacturer / food animals / consumer groups / arsenic-containing product / credentialed media / less used product / /

MedicalCondition

control coccidiosis / parasitic disease / /

Organization

FDA's Center for Veterinary Medicine / Center for Veterinary Medicine's office of Research / U.S. Department of Agriculture's Food Safety Inspection Service / FDA Center for Veterinary Medicine / U.S. Department of Agriculture / FDA's office of Public Affairs / US Federal Reserve / FDA / Food Safety / Center for Veterinary Medicine / office of Public Health Science / /

Person

Stephanie Yao / William Flynn / Helena Bottemiller / David Goldman / Jennifer Corbett / Bill Flynn / Mary Clare / Murray Lumpkin / Stephanie Yao June / David White / Mary Clare Jalonick / Bernadette Dunham / /

Position

Assistant Administrator / Governor / Coordinator / Director / Deputy Commissioner for International Programs / Deputy Director for Science Policy / /

Product

Roxarsone / chicken / Nitro / /

PublishedMedium

Wall Street Journal / /

URL

www.fda.gov / /

SocialTag